AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Development of a New Malaria Vaccine and Breakthrough Efficacy Results
The chapter delves into the creation and success of the R21 malaria vaccine, which has shown efficacy in protecting children against malaria by triggering antibodies and blocking infection by sporozoites. Despite challenges, the vaccine has progressed from phase one and two trials in the UK to further testing in malaria-endemic areas like Kenya and Burkina Faso.